EV/EBITDA:
-16.97-0.25(-1.50%)Summary
- As of today, APLS EV/EBITDA is -16.97, with a fall of -0.25 (-1.50%) during the most recent trading session on October 17, 2025.
- Over the past year, APLS EV/EBITDA has dropped by -1.26 (-8.02%).
- APLS EV/EBITDA is now -345.41% below its all-time high of -3.81.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.5% | +1.5% | +1.5% |
| 1M1 Month | -5.8% | +5.8% | +6.0% |
| 3M3 Months | -21.6% | +21.6% | +22.4% |
| 6M6 Months | -30.5% | +33.3% | +34.7% |
| YTDYTD | +31.3% | -20.7% | -23.2% |
| 1Y1 Year | -8.0% | -8.2% | -12.2% |
| 5Y5 Years | -234.7% | +40.2% | -29.6% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -15.43 | -10.0% | -17.78 | +4.6% |
| 3M | 3-Month | -13.10 | -29.5% | -19.74 | +14.0% |
| 6M | 6-Month | -11.74 | -44.5% | -19.74 | +14.0% |
| 1Y | 1-Year | -11.74 | -44.5% | -26.77 | +36.6% |
| 3Y | 3-Year | -4.27 | -297.4% | -26.77 | +36.6% |
| 5Y | 5-Year | -4.27 | -297.4% | -26.77 | +36.6% |
| All-Time | All-Time | -3.81 | -345.4% | -30.85 | +45.0% |
APLS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.97(+31.3%) |
| 2024 | -24.70(-84.1%) |
| 2023 | -13.42(-50.6%) |
| 2022 | -8.91(-15.7%) |
| Date | Value |
|---|---|
| 2021 | -7.70(+57.5%) |
| 2020 | -18.10(-195.3%) |
| 2019 | -6.13(+2.5%) |
| 2018 | -6.29 |
FAQ
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of APLS is -16.97
What is the all-time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high EV/EBITDA is -3.81
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals, Inc. EV/EBITDA has changed by +7.73 (+31.30%) since the beginning of the year
What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -1.26 (-8.02%)